China Nepstar Chain Drugstore Ltd.(ADR)  

(Public, NYSE:NPD)   Watch this stock  
Find more results for NPD
0.00 (0.00%)
Jul 27 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 2.00 - 2.59
Open     -
Vol / Avg. 0.00/56,951.00
Mkt cap 248.82M
P/E 32.71
Div/yield     -
EPS 0.08
Shares 197.45M
Beta 1.18
Inst. own 1%
Aug 31, 2016
Q2 2016 China Nepstar Chain Drugstore Ltd Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jul 28, 2016
China Nepstar Chain Drugstore Ltd Extraordinary Shareholders Meeting - 10:00PM EDT - Add to calendar
May 31, 2016
Q1 2016 China Nepstar Chain Drugstore Ltd Earnings Release
May 31, 2016
Q1 2016 China Nepstar Chain Drugstore Ltd Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 0.90% 1.23%
Operating margin 1.73% 1.91%
EBITD margin - 3.80%
Return on average assets 1.84% 2.54%
Return on average equity 3.44% 4.68%
Employees 14,017 -
CDP Score - -


6th Floor, Tower B, Xinnengyuan Building Nanhai Road Nanshan District
+86-755-26433366 (Phone)
+86-755-26430889 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


China Nepstar Chain Drugstore Ltd. is a retail drugstore chain in China. The Company provides its customers with pharmacy services and a range of other merchandise, including over-the-counter drugs, nutritional supplements, herbal products, personal care products, family care products, as well as convenience products, including consumable, seasonal and promotional items. The Company operates through the retail drugstore business segment. The Company also offers private label products. It has a network of approximately 1,990 directly operated drugstores spanning over 70 cities across approximately 14 provinces and direct-controlled municipalities in China. The Company offers approximately 2,170 private label products. The Company also operates an Internet Website, It offers approximately 3,210 prescription drugs. It offers approximately 3,360 over-the-counter drugs, including western medicines and traditional Chinese medicines, for the treatment of common diseases.

Officers and directors

Simin Zhang Chairman of the Board
Age: 51
Bio & Compensation  - Reuters
Yingnan Zhang Chief Executive Officer, Director
Bio & Compensation  - Reuters
Zixin Shao Chief Financial Officer
Age: 44
Bio & Compensation  - Reuters
Henry Lu Director
Age: 48
Bio & Compensation  - Reuters
Barry John Buttifant CPA Independent Director
Age: 70
Bio & Compensation  - Reuters
Alistair Eric MacCallum Laband Independent Director
Age: 61
Bio & Compensation  - Reuters